166 related articles for article (PubMed ID: 17445159)
21. High CD4/CD8 ratio in allografts predicts adverse outcomes in unmanipulated HLA-mismatched/haploidentical hematopoietic stem cell transplantation for chronic myeloid leukemia.
Xu LP; Luo XH; Chang YJ; Liu DH; Liu KY; Chen YH; Huang XJ
Ann Hematol; 2009 Oct; 88(10):1015-24. PubMed ID: 19319533
[TBL] [Abstract][Full Text] [Related]
22. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
[TBL] [Abstract][Full Text] [Related]
23. Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies.
Meisel R; Laws HJ; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Schmitz M; Fischer J; Göbel U; Enczmann J; Dilloo D
Biol Blood Marrow Transplant; 2007 Nov; 13(11):1338-45. PubMed ID: 17950920
[TBL] [Abstract][Full Text] [Related]
24. Donor age and degree of HLA matching have a major impact on the outcome of unrelated donor haematopoietic cell transplantation for chronic myeloid leukaemia.
Carreras E; Jiménez M; Gómez-García V; de la Cámara R; Martín C; Martínez F; Iriondo A; Sanz G; Cañizo C; Cabrera R; Sierra J; Vallejo C; López J; Martínez C; Rovira M; Fernández-Rañada JM; Torres A
Bone Marrow Transplant; 2006 Jan; 37(1):33-40. PubMed ID: 16247421
[TBL] [Abstract][Full Text] [Related]
25. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program.
Kimura F; Sato K; Kobayashi S; Ikeda T; Sao H; Okamoto S; Miyamura K; Mori S; Akiyama H; Hirokawa M; Ohto H; Ashida H; Motoyoshi K;
Haematologica; 2008 Nov; 93(11):1686-93. PubMed ID: 18835834
[TBL] [Abstract][Full Text] [Related]
26. Relation of an interleukin-23 receptor gene polymorphism to graft-versus-host disease after hematopoietic-cell transplantation.
Elmaagacli AH; Koldehoff M; Landt O; Beelen DW
Bone Marrow Transplant; 2008 May; 41(9):821-6. PubMed ID: 18209723
[TBL] [Abstract][Full Text] [Related]
27. The activating killer cell immunoglobulin-like receptors as important determinants of acute graft-versus host disease in hematopoietic stem cell transplantation for acute myelogenous leukemia.
Kim HJ; Choi Y; Min WS; Kim TG; Cho BS; Kim SY; Eom KS; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Kim CC
Transplantation; 2007 Nov; 84(9):1082-91. PubMed ID: 17998861
[TBL] [Abstract][Full Text] [Related]
28. Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia.
Moore J; Nivison-Smith I; Goh K; Ma D; Bradstock K; Szer J; Durrant S; Schwarer A; Bardy P; Herrmann R; Dodds A
Biol Blood Marrow Transplant; 2007 May; 13(5):601-7. PubMed ID: 17448920
[TBL] [Abstract][Full Text] [Related]
29. Why cord blood?
Rubinstein P
Hum Immunol; 2006 Jun; 67(6):398-404. PubMed ID: 16728260
[TBL] [Abstract][Full Text] [Related]
30. Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation.
Giebel S; Nowak I; Dziaczkowska J; Czerw T; Wojnar J; Krawczyk-Kulis M; Holowiecki J; Holowiecka-Goral A; Markiewicz M; Kopera M; Karolczyk A; Kyrcz-Krzemien S; Kusnierczyk P
Eur J Haematol; 2009 Oct; 83(4):343-56. PubMed ID: 19500138
[TBL] [Abstract][Full Text] [Related]
31. Lack of effect of donor-recipient Rh mismatch on outcomes after allogeneic hematopoietic stem cell transplantation.
Wirk B; Klumpp TR; Ulicny J; Herman JH; Gajewski JL; Martin ME; Emmons RV; Mangan KF
Transfusion; 2008 Jan; 48(1):163-8. PubMed ID: 17900280
[TBL] [Abstract][Full Text] [Related]
32. Human leukocyte antigen matching in unrelated donor hematopoietic cell transplantation.
Petersdorf EW; Malkki M
Semin Hematol; 2005 Apr; 42(2):76-84. PubMed ID: 15846573
[TBL] [Abstract][Full Text] [Related]
33. Impact of HLA-DPB1 allelic and single amino acid mismatches on HSCT.
Ludajic K; Balavarca Y; Bickeböller H; Pohlreich D; Kouba M; Dobrovolna M; Vrana M; Rosenmayr A; Fischer GF; Fae I; Kalhs P; Greinix HT
Br J Haematol; 2008 Jul; 142(3):436-43. PubMed ID: 18544086
[TBL] [Abstract][Full Text] [Related]
34. My approach to the immunogenetics of haematopoietic stem cell transplant matching.
Sage D
J Clin Pathol; 2010 Mar; 63(3):194-8. PubMed ID: 20203219
[TBL] [Abstract][Full Text] [Related]
35. The clinical implications of HLA mismatches in unrelated donor haematopoietic cell transplantation.
Shaw BE
Int J Immunogenet; 2008 Aug; 35(4-5):367-74. PubMed ID: 18976440
[TBL] [Abstract][Full Text] [Related]
36. Innovative approaches to hematopoietic stem cell transplantation for patients with thalassemia.
Locatelli F; De Stefano P
Haematologica; 2005 Dec; 90(12):1592-4. PubMed ID: 16330431
[No Abstract] [Full Text] [Related]
37. Reduced-intensity conditioning for allogeneic stem cell transplantation in patients with chronic myeloid leukemia is associated with better overall survival but inferior disease-free survival when compared with myeloablative conditioning - a retrospective study of the Czech National Hematopoietic Stem Cell Transplantation Registry.
Faber E; Koza V; Vitek A; Mayer J; Sedlacek P; Zak P; Zapletalova J; Benesova K; Krejcova H; Steinerova K; Maresova I; Cetkovsky P;
Neoplasma; 2007; 54(5):443-6. PubMed ID: 17688375
[TBL] [Abstract][Full Text] [Related]
38. Allogeneic stem cell transplantation in children with leukemia using human leukocyte antigen-mismatched unrelated donors.
Sedlacek P; Formankova R; Mejstrikova E; Keslova P; Hubacek P; Dobrovolna M; Vrana M; Kupkova L; Pittrova H; Stary J
Pediatr Transplant; 2008 Feb; 12(1):24-31. PubMed ID: 18186885
[TBL] [Abstract][Full Text] [Related]
39. Partially matched related donor transplantation can achieve outcomes comparable with unrelated donor transplantation for patients with hematologic malignancies.
Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Yu W; Huan C; Yu-Hong C; Wei H; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Feng-Rong W; Fei-Fei T
Clin Cancer Res; 2009 Jul; 15(14):4777-83. PubMed ID: 19584148
[TBL] [Abstract][Full Text] [Related]
40. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
Strober S
Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]